JP2015529192A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529192A5
JP2015529192A5 JP2015526970A JP2015526970A JP2015529192A5 JP 2015529192 A5 JP2015529192 A5 JP 2015529192A5 JP 2015526970 A JP2015526970 A JP 2015526970A JP 2015526970 A JP2015526970 A JP 2015526970A JP 2015529192 A5 JP2015529192 A5 JP 2015529192A5
Authority
JP
Japan
Prior art keywords
alkyl
dihydro
benzodiazepine
carboxamide
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015526970A
Other languages
English (en)
Japanese (ja)
Other versions
JP6333251B2 (ja
JP2015529192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/066931 external-priority patent/WO2014026997A1/de
Publication of JP2015529192A publication Critical patent/JP2015529192A/ja
Publication of JP2015529192A5 publication Critical patent/JP2015529192A5/ja
Application granted granted Critical
Publication of JP6333251B2 publication Critical patent/JP6333251B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015526970A 2012-08-16 2013-08-13 2,3−ベンゾジアゼピン類 Expired - Fee Related JP6333251B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102012214602 2012-08-16
DE102012214602.4 2012-08-16
DE102013202104.6 2013-02-08
DE102013202104 2013-02-08
PCT/EP2013/066931 WO2014026997A1 (de) 2012-08-16 2013-08-13 2,3-benzodiazepine

Publications (3)

Publication Number Publication Date
JP2015529192A JP2015529192A (ja) 2015-10-05
JP2015529192A5 true JP2015529192A5 (cg-RX-API-DMAC7.html) 2018-02-08
JP6333251B2 JP6333251B2 (ja) 2018-05-30

Family

ID=48979774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015526970A Expired - Fee Related JP6333251B2 (ja) 2012-08-16 2013-08-13 2,3−ベンゾジアゼピン類

Country Status (22)

Country Link
US (1) US9890147B2 (cg-RX-API-DMAC7.html)
EP (1) EP2885286B1 (cg-RX-API-DMAC7.html)
JP (1) JP6333251B2 (cg-RX-API-DMAC7.html)
KR (1) KR20150041787A (cg-RX-API-DMAC7.html)
CN (1) CN104755473B (cg-RX-API-DMAC7.html)
AR (1) AR092129A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013304146A1 (cg-RX-API-DMAC7.html)
CA (1) CA2881996A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015000337A1 (cg-RX-API-DMAC7.html)
CR (1) CR20150066A (cg-RX-API-DMAC7.html)
DO (1) DOP2015000022A (cg-RX-API-DMAC7.html)
EA (1) EA201590356A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP15005376A (cg-RX-API-DMAC7.html)
ES (1) ES2628005T3 (cg-RX-API-DMAC7.html)
IL (1) IL236898A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015001880A (cg-RX-API-DMAC7.html)
PE (1) PE20150729A1 (cg-RX-API-DMAC7.html)
PH (1) PH12015500323A1 (cg-RX-API-DMAC7.html)
TN (1) TN2015000051A1 (cg-RX-API-DMAC7.html)
TW (1) TW201408651A (cg-RX-API-DMAC7.html)
UY (1) UY34977A (cg-RX-API-DMAC7.html)
WO (1) WO2014026997A1 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568722B (zh) 2012-06-15 2017-02-01 葛蘭馬克製藥公司 作爲mPGES-1抑制劑之三唑酮化合物
WO2014128067A1 (de) * 2013-02-19 2014-08-28 Bayer Pharma Aktiengesellschaft Bicyclo- und spirocyclisch substituierte 2,3-benzodiazepine
EP2970282B1 (en) 2013-03-15 2019-08-21 Incyte Holdings Corporation Tricyclic heterocycles as bet protein inhibitors
AR096837A1 (es) 2013-07-08 2016-02-03 Incyte Corp Heterociclos tricíclicos como inhibidores de proteínas bet
US9399640B2 (en) 2013-11-26 2016-07-26 Incyte Corporation Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
US9315501B2 (en) 2013-11-26 2016-04-19 Incyte Corporation Bicyclic heterocycles as BET protein inhibitors
US9309246B2 (en) 2013-12-19 2016-04-12 Incyte Corporation Tricyclic heterocycles as BET protein inhibitors
WO2015121226A1 (de) * 2014-02-13 2015-08-20 Bayer Pharma Aktiengesellschaft 6-substituierte 2,3-benzodiazepine
MY207899A (en) 2014-04-23 2025-03-27 Incyte Holdings Corp 1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins
ES2855225T3 (es) 2014-09-15 2021-09-23 Incyte Corp Heterociclos tricíclicos para su uso como inhibidores de proteínas BET
JP6930913B2 (ja) 2014-10-14 2021-09-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California 炎症を阻害するためのcdk9及びbrd4阻害剤の使用法
WO2016062688A1 (de) * 2014-10-23 2016-04-28 Bayer Pharma Aktiengesellschaft 1-phenyl-4,5-dihydro-3h-2,3-benzodiazepine derivatives
GB201504694D0 (en) 2015-03-19 2015-05-06 Glaxosmithkline Ip Dev Ltd Covalent conjugates
WO2017005711A1 (de) * 2015-07-09 2017-01-12 Bayer Pharma Aktiengesellschaft Phosphor- und schwefel-substituierte benzodiazepin-derivate
WO2017063959A1 (de) * 2015-10-15 2017-04-20 Bayer Pharma Aktiengesellschaft N-sulfoximinophenyl-substituierte benzodiazepin-derivate als bet-proteininhibitoren
US20170121347A1 (en) 2015-10-29 2017-05-04 Incyte Corporation Amorphous solid form of a bet protein inhibitor
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
DE102017005091A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
DE102017005089A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
DK3472157T3 (da) 2016-06-20 2023-05-01 Incyte Corp Krystallinske faste former af en bet-inhibitor
CN109563438B (zh) * 2016-08-15 2022-11-04 奇华顿股份有限公司 有机化合物
CN109406685B (zh) * 2018-12-27 2021-05-25 湖南泰新医药科技有限公司 一种分离卡非佐米和其异构体的高效液相色谱方法
WO2020242923A1 (en) * 2019-05-24 2020-12-03 Emory University Uses of radiation and benzodiazepine derivatives in cancer therapies
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN114920727B (zh) * 2022-05-26 2023-07-25 重庆华邦制药有限公司 一种卢帕他定的制备方法
WO2023229535A1 (en) 2022-05-27 2023-11-30 Engine Biosciences Pte. Ltd. Bet polypeptide therapeutic agents for generating synthetic lethality in tumors

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483186A (en) * 1966-11-22 1969-12-09 Mcneilab Inc 2-benzazepine derivatives
HU208429B (en) 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity
EP0638560A4 (en) 1991-10-11 1995-03-29 Yoshitomi Pharmaceutical MEDICINE FOR OSTEOPOROSIS AND DIAZEPINE COMPOUND *.
WO1994006802A1 (fr) 1992-09-18 1994-03-31 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienodiazepine et son utilisation medicinale
WO1994026718A1 (fr) 1993-05-13 1994-11-24 Yoshitomi Pharmaceutical Industries, Ltd. Compose de 3-aminoazepine et son utilisation pharmaceutique
DE19604920A1 (de) 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives
CA2258053A1 (en) 1996-06-12 1997-12-18 Yoshihisa Yamamoto Cytokine production inhibitors, triazepine compounds, and intermediates thereof
ATE227727T1 (de) 1996-09-13 2002-11-15 Mitsubishi Pharma Corp Thienotriazolodiazepinverbindungen und ihre medizinischen anwendungen
US6887867B2 (en) 2000-06-16 2005-05-03 Transgenomic, Inc. 5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
CA2482382A1 (en) 2002-04-12 2003-10-23 Pfizer Inc. Pyrazole compounds as anti-inflammatory and analgesic agents
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
GB0425196D0 (en) 2004-11-15 2004-12-15 Black James Foundation Gastrin and cholecystokinin receptor ligands
GB0503962D0 (en) 2005-02-25 2005-04-06 Kudos Pharm Ltd Compounds
WO2006129623A1 (ja) 2005-05-30 2006-12-07 Mitsubishi Tanabe Pharma Corporation チエノトリアゾロジアゼピン化合物及びその医薬としての用途
EA016087B1 (ru) * 2005-12-30 2012-02-28 Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг Оптические изомеры дигидро-2,3-бензодиазепинов и их стереоселективный синтез
DE102006042439A1 (de) 2006-09-09 2008-03-27 Saltigo Gmbh Verfahren zur katalytischen Herstellung von aromatischen oder heteroaromatischen Nitrilen
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
JP2008308491A (ja) * 2007-05-11 2008-12-25 Gunma Univ がん治療用の遊走阻害剤
KR101600634B1 (ko) 2007-12-28 2016-03-07 미쓰비시 타나베 파마 코퍼레이션 항암제
US9062024B2 (en) * 2009-09-28 2015-06-23 Nippon Soda Co., Ltd. Nitrogen-containing heterocyclic compound and salt thereof, and a fungicide for agricultural and horticultural use
GB0919426D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
CN102781943B (zh) 2009-11-05 2016-10-05 葛兰素史密丝克莱恩有限责任公司 苯并二氮杂*溴结构域抑制剂
NZ599258A (en) 2009-11-05 2014-05-30 Glaxosmithkline Llc Benzodiazepine bromodomain inhibitor
GB0919432D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Use
BR122014024883A2 (pt) * 2010-05-14 2019-08-20 Dana-Farber Cancer Institute, Inc. Compostos no tratamento de neoplasia
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) * 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos

Similar Documents

Publication Publication Date Title
JP2015529192A5 (cg-RX-API-DMAC7.html)
US11524938B2 (en) Aromatic sulfonamide derivatives
AU2014291711B2 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
ES2727376T3 (es) Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
JP2019504821A5 (cg-RX-API-DMAC7.html)
JP2017530999A5 (cg-RX-API-DMAC7.html)
AU2018309356B2 (en) Dihydrooxadiazinones
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
AU2013304146A1 (en) 2,3-benzodiazepines
EP3510024A1 (en) Pyridyl substituted indole compounds
SA517380830B1 (ar) 2-(مورفولين-4- يل)-7،1- نفثيريدينات
JP2019517596A5 (cg-RX-API-DMAC7.html)
JP7406592B2 (ja) 置換窒素含有化合物
CA2521201A1 (en) Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors
RU2019123319A (ru) Пиразолопиримидины и способы их применения
US11660301B2 (en) Combination of ATR kinase inhibitors with PARP inhibitors
HRP20160421T1 (hr) Derivat azola
JP2022544952A (ja) [1,2,4]トリアゾロ[1,5-c]キナゾリン-5-アミン
JPWO2021030537A5 (cg-RX-API-DMAC7.html)
JPWO2022008911A5 (cg-RX-API-DMAC7.html)
CA3022793C (en) Aromatic sulfonamide derivatives
RU2023132437A (ru) Производное бензамида, способ его получения и фармацевтическая композиция для профилактики или лечения рака, содержащая его в качестве активного ингредиента
EA040608B1 (ru) Ароматические сульфонамидные производные
BR112018072549B1 (pt) Derivados de sulfonamida aromática, seus intermediários, seus usos, e composição farmacêutica